N@N

Market Maker Surveillance Report. BSX, CMED, SMOD, ITUB, POTG, P, Bullishly Biased Price Friction For Wednesday, June 15th 201

^{Published on 2011-06-15 17:50:33 - WOPRAI}
 

June 15, 2011 / M2 PRESSWIRE / BUYINS.NET / www.buyins.net, announced today its proprietary Market Maker Friction Factor Report for Wednesday. Since October 2008 market makers are now required to be on the bid as much as they are on the offer and for like amounts of stock. This Fair Market Making Requirement is designed to prevent market makers from manipulating stock prices. On Wednesday there were 4151 companies with "abnormal" market making, 1625 companies with positive Friction Factors and 5334 companies with negative Friction Factors. Here is a list of the top companies with Abnormal Price Friction (bullish bias) in their stock prices. This means that there was more selling than buying in the stocks and their stock prices rose. BOSTON SCIENTIFIC CORP (NYSE:BSX), CHINA MEDICAL TECH-SPON ADR (NASDAQ:CMED), SMART MODULAR TECHNOLOGIES (NASDAQ:SMOD), ITAU UNIBANCO HLDNG-PREF ADR (NYSE:ITUB), (OTC:POTG), (:P). To access Friction Factor, Naked Short Data and SqueezeTrigger Prices on all stocks please visit http://www.buyins.net .

Market Maker Friction Factor is shown in the chart below:

     Symbol     Change       Percent      Buy Volume      Buy %%       Sell Volume     Sell %%      Net Volume      Friction
     BSX        $0.210       3.12%        10,832,792      26.89%       11,481,516      28.50%       -648,724        Abnormal
     CMED       $0.870       10.77%       981,020         38.93%       1,533,409       60.86%       -552,389        Abnormal
     SMOD       $0.010       0.11%        544,129         32.72%       1,119,047       67.28%       -574,918        Abnormal
     ITUB       $0.180       0.80%        4,415,602       20.12%       6,300,593       28.71%       -1,884,991      Abnormal
     POTG       $0.165       149.55%      14,455,227      42.29%       18,315,184      53.58%       -3,859,957      Abnormal
     P          $17.470      0.00%        8,761,378       20.82%       10,011,569      23.79%       -1,250,191      Abnormal

For example, the chart above shows BSX with 648,724 greater shares of selling than buying (NetVol) and the stock price was up $0.21000. This means the Market Makers were trading the stock in a way inconsistent with normal supply and demand (Economics 101); more selling than buying should cause prices to drop.

BOSTON SCIENTIFIC CORP (NYSE:BSX) - Boston Scientific Corporation develops, manufactures, and markets medical devices used in various interventional medical specialties worldwide. It offers cardiac rhythm management products, which monitor the heart and deliver electricity to treat cardiac abnormalities; and RF generators, intracardiac ultrasound and steerable ablation catheters, and diagnostic catheters for the diagnosis and treatment of cardiac arrhythmias. The company also provides interventional cardiology products, such as coronary stent systems, coronary revascularization products to treat patients with atherosclerosis and intraluminal catheter-directed ultrasound imaging catheters and systems; vascular access products, balloon catheters, stents and peripheral vascular catheters, wires, and accessories, as well as products for peripheral embolization procedures; and biliary stents, drainage catheters, and micro-puncture sets to treat, diagnose, and ease various forms of benign and malignant tumors. In addition, it offers coated and uncoated detachable coils, micro-delivery stents, micro-guidewires, micro-catheters, guiding catheters, and embolics to neuro-interventional radiologists and neurosurgeons to treat diseases of the neurovascular system; and endoscopy and interventional bronchoscopy products to diagnose and treat various digestive diseases, as well as pulmonary disease systems within the airway and lungs. Further, the company provides urology/womens health products to treat patients with urinary stone disease, benign prostatic hyperplasia, stress urinary incontinence, pelvic organ prolapse, and excessive uterine bleeding; and spinal cord stimulation system for the management of chronic intractable pain of the trunk and/or limbs. Boston Scientific Corporation markets its products through direct sales force, and a network of distributors and dealers. The company was founded in 1979 and is headquartered in Natick, Massachusetts with additional offices in Tokyo, Japan and Paris, France.

CHINA MEDICAL TECH-SPON ADR (NASDAQ:CMED) - China Medical Technologies, Inc., a medical device company, develops, manufactures, and markets advanced immunodiagnostic and molecular diagnostic products primarily in the Peoples Republic of China. The company offers IVD products, which utilize ECLIA technology, fluorescent in situ hybridization (FISH) technology, and surface plasmon resonance (SPR) technology to detect and monitor various diseases and disorders through the laboratory evaluation and analysis of blood, urine, or other body fluids. It offers ECLIA system, which includes ECLIA analyzer for detecting the minute levels of light triggered by combining reagents with body fluid samples to produce diagnostic results; and reagent kits for detecting and monitoring various types of diseases and disorders, including thyroid disorders, diabetes, hepatitis, SARS, Down syndrome, liver fibrosis, disorders related to reproduction and growth, and various types of tumors. The company also provides FISH imaging analysis system that enables medical practitioners to visualize and locate DNA sequences in human cells for identifying chromosomal abnormalities, using FISH technology; and offers FISH probes used for prenatal and cancer management. The FISH probes are used for the detection and monitoring the course of bladder cancer; treatment of breast cancer; prediction and diagnosis of cervical cancer; diagnosis and prognosis of various leukemias and multiple myeloma; detection of epidermal growth factor receptor abnormalities; detection of Trisomy 21, Trisomy 18, Trisomy 13, Turner syndrome, Trisomy X, XYY syndrome, DiGeorge syndrome, and triploidy; and diagnosis of prostate cancer. In addition, it offers HPV-DNA chips and SPR-based analysis system for the diagnosis of human papillomavirus (HPV) infection and genotyping of HPV. The company sells its products through distributors. China Medical Technologies, Inc. was founded in 1999 and is based in Beijing, the Peoples Republic of China.

SMART MODULAR TECHNOLOGIES (NASDAQ:SMOD) - SMART Modular Technologies (WWH), Inc. designs, manufactures, and supplies value added subsystems to original equipment manufacturers worldwide. Its subsystem products include memory modules; solid state drives (SSD); and embedded computing and thin film transistor-liquid crystal display (TFT-LCD) products. The company operates in two segments, namely Memory, Display, and Embedded segment, and Adtron segment. The Memory, Display, and Embedded segment offers dynamic random access memory (DRAM) modules, flash memory cards and modules, and SRAM based SIMMs, DIMMs, and SO-DIMMs for industrial and other applications. The SRAM modules are also used in communication systems, point of sale terminals, electronic verification equipment, industrial instrumentation, medical instruments, disk drives, servers, graphics products, and workstations. This segment also offers eFlashTools and FlashTools, embedded computing products, and display products targeting gaming, kiosk, ATM, point-of-service, digital signage, and industrial control systems. The Adtron segment offers products, such as XceedLite, XceedUltra, XceedUltraX, Xceed IOPs, XceedSecure, XceedSCSI, and Xcel-10 that are industrial grade storage products. These products target defense, aerospace, industrial automation, medical, transportation, and enterprise industries. SMART Modular Technologies (WWH), Inc. also offers custom supply chain services, including procurement, logistics, inventory management, temporary warehousing, kitting, and packaging services. It sells its products directly and through a network of independent sales representatives principally to major OEMs that compete in the computing, networking, communications, printer, storage, and industrial markets. The company was founded in 1988 and is headquartered in Newark, California.

ITAU UNIBANCO HLDNG-PREF ADR (NYSE:ITUB) - Ita Unibanco Holding S.A., together with its subsidiaries, provides commercial, corporate, and investment banking services to individuals, small and middle-market companies, and large corporations in Brazil and internationally. The companys deposit products include demand, savings, time, and other deposits, as well as deposits from banks. Its loan portfolio comprises commercial, real estate, lease financing, government, agricultural, and personal loans. The company also offers pension fund and mutual fund management, securities services, credit cards, and asset management services; life, property, casualty, and vehicle insurance, as well as private retirement plans and capitalization products; and credit products, such as investment capital loans, working capital loans, inventory financing, equipment leasing services, and letters of credit. In addition, it provides collection and electronic payment services; credit card transactions; factoring, corporate finance, and insurance brokerage and trading; and vehicle lending, private banking, and treasury services. Further, the company offers financial products, such as trade financing, loans from multilateral credit agencies, off-shore loans, international cash management services, foreign exchange, letters of credit, guarantees required in international bidding processes, derivatives for hedging or proprietary trading purposes, structured transactions, and international capital markets offerings. As of December 31, 2009, it operated 3,936 branches, 948 customer site branches, and 30,276 automated teller machines in Brazil and internationally. Ita Unibanco Holding S.A. was formerly known as Ita Unibanco Banco Mltiplo S.A. and changed its name to Ita Unibanco Holding S.A. in April 2009. The company was founded in 1944 and is headquartered in Sao Paulo, Brazil. Ita Unibanco Holding S.A. operates as a subsidiary of Itau Unibanco Participacoes S.A.

(OTC:POTG) -

(:P) -

About BUYINS.NET

BUYINS.NET, www.buyins.net , monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:

REGULATORY & COMPLIANCE NEWS

Friction Factor -- market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements"

RegSHO Naked Shorts -- tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO

INVESTMENTS & TRADING

SqueezeTrigger -- 29 billion cell database tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock.

Earnings Edge -- predicts probability, price move and length of move before and after all US stock earnings reports.

Seasonality -- predicts probability, price move and length of move based on exact time of year for all US stocks.

Group Trader -- tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups.

Pattern Scan -- automates tracking of every technical pattern and predicts time and size of move in all stocks.

GATS (Global Automated Trading System) -- tracks all known trading strategies and qualifies and quantifies which are working best in real time.

DISCLAIMER:

BUYINS.NET is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. BUYINS.NET has not been compensated by any of the above mentioned companies. Past performance is not indicative of future results. Please visit our web site, www.buyins.net , for complete risks and disclosures.

Contact:

BUYINS.NET Thomas Ronk 800-715-9999 tom@buyins.net www.buyins.net